A two-year-old boy from north London who was the youngest person to be treated for cancer with Nanoknife technology is now ...

After 18 months, George was declared cancer-free. Johnathan said that the family was proud their son’s treatment plan was ...

The youngest person to undergo cancer treatment using Nanoknife technology is now free from cancer.As per BBC, a two-year-old ...

AngioDynamics has won US Food and Drug Administration (FDA) clearance for its NanoKnife system to be used in prostate cancer patients. The system, which was already FDA-cleared for the surgical ...

AngioDynamics has obtained an FDA green light for its NanoKnife prostate cancer ablation system, designed to precisely target and destroy tissue without delivering excess heat and the unintended ...

Shares of AngioDynamics hit a 52-week high after the company's NanoKnife System for prostate tissue ablation received regulatory clearance. The stock jumped almost 35% to a high of $9.42 in early ...

The Company received clearance for the NanoKnife System for prostate tissue ablation following the completion of the pivotal PRESERVE clinical study and submission of results to the FDA in September.

AngioDynamics (ANGO) announced it received U.S. FDA 510(k) clearance for the NanoKnife System for prostate tissue ablation. Pick the best stocks and maximize your portfolio: Published first on ...

George was the youngest person to be treated for cancer with Nanoknife technology - also known as irreversible electroporation [Handout] A two-year-old boy from north London who was the youngest ...